HEADER TRANSFERASE/TRANSFERASE INHIBITOR 02-AUG-13 4M13 TITLE CRYSTAL STRUCTURE OF ITK IN COMPLEX WITH COMPOUND 8 [4- TITLE 2 (CARBAMOYLAMINO)-1-(7-PROPOXYNAPHTHALEN-1-YL)-1H-PYRAZOLE-3- TITLE 3 CARBOXAMIDE] COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE ITK/TSK; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 354-620; COMPND 5 SYNONYM: INTERLEUKIN-2-INDUCIBLE T-CELL KINASE, IL-2-INDUCIBLE T-CELL COMPND 6 KINASE, KINASE EMT, T-CELL-SPECIFIC KINASE, TYROSINE-PROTEIN KINASE COMPND 7 LYK; COMPND 8 EC: 2.7.10.2; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ITK, EMT, LYK; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR S.HAN,N.L.CASPERS REVDAT 3 28-FEB-24 4M13 1 REMARK SEQADV REVDAT 2 04-JUN-14 4M13 1 JRNL REVDAT 1 02-APR-14 4M13 0 JRNL AUTH S.HAN,R.M.CZERWINSKI,N.L.CASPERS,D.C.LIMBURG,W.DING,H.WANG, JRNL AUTH 2 J.F.OHREN,F.RAJAMOHAN,T.J.MCLELLAN,R.UNWALLA,C.CHOI, JRNL AUTH 3 M.D.PARIKH,N.SETH,J.EDMONDS,C.PHILLIPS,S.SHAKYA,X.LI, JRNL AUTH 4 V.SPAULDING,S.HUGHES,A.COOK,C.ROBINSON,J.P.MATHIAS, JRNL AUTH 5 I.NAVRATILOVA,Q.G.MEDLEY,D.R.ANDERSON,R.G.KURUMBAIL, JRNL AUTH 6 A.AULABAUGH JRNL TITL SELECTIVELY TARGETING AN INACTIVE CONFORMATION OF JRNL TITL 2 INTERLEUKIN-2-INDUCIBLE T-CELL KINASE BY ALLOSTERIC JRNL TITL 3 INHIBITORS. JRNL REF BIOCHEM.J. V. 460 211 2014 JRNL REFN ISSN 0264-6021 JRNL PMID 24593284 JRNL DOI 10.1042/BJ20131139 REMARK 2 REMARK 2 RESOLUTION. 1.85 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.2 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.85 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.81 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 95.9 REMARK 3 NUMBER OF REFLECTIONS : 21364 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.190 REMARK 3 R VALUE (WORKING SET) : 0.187 REMARK 3 FREE R VALUE : 0.232 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.320 REMARK 3 FREE R VALUE TEST SET COUNT : 1136 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 11 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.85 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.94 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 95.90 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2948 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.1988 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2759 REMARK 3 BIN R VALUE (WORKING SET) : 0.1958 REMARK 3 BIN FREE R VALUE : 0.2423 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 6.41 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 189 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2123 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 26 REMARK 3 SOLVENT ATOMS : 189 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 26.79 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 30.73 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -4.74000 REMARK 3 B22 (A**2) : 0.30050 REMARK 3 B33 (A**2) : 4.43950 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.89180 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.244 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.155 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.939 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.917 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2227 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 3025 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 777 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 54 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 358 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2227 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 270 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 2744 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.01 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.29 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 15.77 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|355 - A|618 } REMARK 3 ORIGIN FOR THE GROUP (A): 5.0989 2.7955 10.8929 REMARK 3 T TENSOR REMARK 3 T11: -0.0661 T22: -0.0577 REMARK 3 T33: -0.0651 T12: -0.0088 REMARK 3 T13: -0.0039 T23: -0.0015 REMARK 3 L TENSOR REMARK 3 L11: 0.2391 L22: 0.8179 REMARK 3 L33: 0.8124 L12: -0.2703 REMARK 3 L13: -0.1014 L23: 0.1128 REMARK 3 S TENSOR REMARK 3 S11: 0.0033 S12: 0.0041 S13: 0.0114 REMARK 3 S21: 0.0407 S22: 0.0070 S23: -0.0219 REMARK 3 S31: 0.0107 S32: 0.0265 S33: -0.0103 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4M13 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 09-AUG-13. REMARK 100 THE DEPOSITION ID IS D_1000081332. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-SEP-11 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.2 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : MIRROR REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : PSI PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 21496 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.850 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.9 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.85 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.88 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: BUSTER 2.11.2 REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.94 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.16 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 12% PEG3350, 0.1M MG ACETATE, 0.1 M REMARK 280 HEPES, PH 7.2, VAPOR DIFFUSION, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 34.45000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: AS PER THE AUTHORS THE BIOLOGICAL ASSEMBLY IS UNKNOWN REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 352 REMARK 465 SER A 353 REMARK 465 GLY A 354 REMARK 465 GLY A 619 REMARK 465 LEU A 620 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 384 12.14 57.56 REMARK 500 LYS A 385 -83.23 -118.25 REMARK 500 ARG A 481 -24.24 90.49 REMARK 500 ASP A 482 47.66 -145.80 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 1E0 A 701 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4M0Y RELATED DB: PDB REMARK 900 RELATED ID: 4M0Z RELATED DB: PDB REMARK 900 RELATED ID: 4M12 RELATED DB: PDB REMARK 900 RELATED ID: 4M14 RELATED DB: PDB REMARK 900 RELATED ID: 4M15 RELATED DB: PDB DBREF 4M13 A 354 620 UNP Q08881 ITK_HUMAN 354 620 SEQADV 4M13 GLY A 352 UNP Q08881 EXPRESSION TAG SEQADV 4M13 SER A 353 UNP Q08881 EXPRESSION TAG SEQADV 4M13 ARG A 596 UNP Q08881 LYS 596 CONFLICT SEQRES 1 A 269 GLY SER GLY LYS TRP VAL ILE ASP PRO SER GLU LEU THR SEQRES 2 A 269 PHE VAL GLN GLU ILE GLY SER GLY GLN PHE GLY LEU VAL SEQRES 3 A 269 HIS LEU GLY TYR TRP LEU ASN LYS ASP LYS VAL ALA ILE SEQRES 4 A 269 LYS THR ILE ARG GLU GLY ALA MET SER GLU GLU ASP PHE SEQRES 5 A 269 ILE GLU GLU ALA GLU VAL MET MET LYS LEU SER HIS PRO SEQRES 6 A 269 LYS LEU VAL GLN LEU TYR GLY VAL CYS LEU GLU GLN ALA SEQRES 7 A 269 PRO ILE CYS LEU VAL PHE GLU PHE MET GLU HIS GLY CYS SEQRES 8 A 269 LEU SER ASP TYR LEU ARG THR GLN ARG GLY LEU PHE ALA SEQRES 9 A 269 ALA GLU THR LEU LEU GLY MET CYS LEU ASP VAL CYS GLU SEQRES 10 A 269 GLY MET ALA TYR LEU GLU GLU ALA CYS VAL ILE HIS ARG SEQRES 11 A 269 ASP LEU ALA ALA ARG ASN CYS LEU VAL GLY GLU ASN GLN SEQRES 12 A 269 VAL ILE LYS VAL SER ASP PHE GLY MET THR ARG PHE VAL SEQRES 13 A 269 LEU ASP ASP GLN TYR THR SER SER THR GLY THR LYS PHE SEQRES 14 A 269 PRO VAL LYS TRP ALA SER PRO GLU VAL PHE SER PHE SER SEQRES 15 A 269 ARG TYR SER SER LYS SER ASP VAL TRP SER PHE GLY VAL SEQRES 16 A 269 LEU MET TRP GLU VAL PHE SER GLU GLY LYS ILE PRO TYR SEQRES 17 A 269 GLU ASN ARG SER ASN SER GLU VAL VAL GLU ASP ILE SER SEQRES 18 A 269 THR GLY PHE ARG LEU TYR LYS PRO ARG LEU ALA SER THR SEQRES 19 A 269 HIS VAL TYR GLN ILE MET ASN HIS CYS TRP ARG GLU ARG SEQRES 20 A 269 PRO GLU ASP ARG PRO ALA PHE SER ARG LEU LEU ARG GLN SEQRES 21 A 269 LEU ALA GLU ILE ALA GLU SER GLY LEU HET 1E0 A 701 45 HETNAM 1E0 4-(CARBAMOYLAMINO)-1-(7-PROPOXYNAPHTHALEN-1-YL)-1H- HETNAM 2 1E0 PYRAZOLE-3-CARBOXAMIDE FORMUL 2 1E0 C18 H19 N5 O3 FORMUL 3 HOH *189(H2 O) HELIX 1 1 ASP A 359 SER A 361 5 3 HELIX 2 2 SER A 399 MET A 411 1 13 HELIX 3 3 CYS A 442 GLN A 450 1 9 HELIX 4 4 ALA A 455 ALA A 476 1 22 HELIX 5 5 ALA A 484 ARG A 486 5 3 HELIX 6 6 GLU A 492 GLN A 494 5 3 HELIX 7 7 GLY A 502 PHE A 506 5 5 HELIX 8 8 ASP A 509 SER A 514 1 6 HELIX 9 9 PRO A 521 ALA A 525 5 5 HELIX 10 10 SER A 526 SER A 533 1 8 HELIX 11 11 SER A 536 SER A 553 1 18 HELIX 12 12 SER A 563 THR A 573 1 11 HELIX 13 13 SER A 584 TRP A 595 1 12 HELIX 14 14 ARG A 598 ARG A 602 5 5 HELIX 15 15 ALA A 604 SER A 618 1 15 SHEET 1 A 5 LEU A 363 SER A 371 0 SHEET 2 A 5 LEU A 376 TRP A 382 -1 O LEU A 379 N GLN A 367 SHEET 3 A 5 ASP A 386 THR A 392 -1 O ILE A 390 N HIS A 378 SHEET 4 A 5 CYS A 432 GLU A 436 -1 O PHE A 435 N ALA A 389 SHEET 5 A 5 LEU A 421 CYS A 425 -1 N GLY A 423 O VAL A 434 SHEET 1 B 2 CYS A 488 VAL A 490 0 SHEET 2 B 2 ILE A 496 VAL A 498 -1 O LYS A 497 N LEU A 489 CISPEP 1 ALA A 429 PRO A 430 0 -0.89 SITE 1 AC1 16 PHE A 403 ALA A 407 MET A 410 LEU A 413 SITE 2 AC1 16 VAL A 419 GLN A 420 LEU A 421 GLY A 423 SITE 3 AC1 16 VAL A 424 PHE A 435 SER A 499 ASP A 500 SITE 4 AC1 16 PHE A 501 PHE A 506 HOH A 869 HOH A 887 CRYST1 40.520 68.900 49.460 90.00 106.88 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.024679 0.000000 0.007489 0.00000 SCALE2 0.000000 0.014514 0.000000 0.00000 SCALE3 0.000000 0.000000 0.021129 0.00000 CONECT 2131 2132 2135 2143 CONECT 2132 2131 2133 CONECT 2133 2132 2134 2140 CONECT 2134 2133 2135 2136 CONECT 2135 2131 2134 2157 CONECT 2136 2134 2137 2158 CONECT 2137 2136 2138 2139 CONECT 2138 2137 2159 2160 CONECT 2139 2137 CONECT 2140 2133 2141 2142 CONECT 2141 2140 2161 2162 CONECT 2142 2140 CONECT 2143 2131 2144 2147 CONECT 2144 2143 2145 2163 CONECT 2145 2144 2146 2164 CONECT 2146 2145 2148 2165 CONECT 2147 2143 2148 2152 CONECT 2148 2146 2147 2149 CONECT 2149 2148 2150 2166 CONECT 2150 2149 2151 2167 CONECT 2151 2150 2152 2153 CONECT 2152 2147 2151 2168 CONECT 2153 2151 2154 CONECT 2154 2153 2155 2169 2170 CONECT 2155 2154 2156 2171 2172 CONECT 2156 2155 2173 2174 2175 CONECT 2157 2135 CONECT 2158 2136 CONECT 2159 2138 CONECT 2160 2138 CONECT 2161 2141 CONECT 2162 2141 CONECT 2163 2144 CONECT 2164 2145 CONECT 2165 2146 CONECT 2166 2149 CONECT 2167 2150 CONECT 2168 2152 CONECT 2169 2154 CONECT 2170 2154 CONECT 2171 2155 CONECT 2172 2155 CONECT 2173 2156 CONECT 2174 2156 CONECT 2175 2156 MASTER 267 0 1 15 7 0 4 6 2338 1 45 21 END